Open Access
Issue
4open
Volume 3, 2020
Article Number 6
Number of page(s) 9
Section Life Sciences - Medicine
DOI https://doi.org/10.1051/fopen/2020006
Published online 18 June 2020
  1. World Health Organization (WHO) (2020), Coronavirus disease 2019 (COVID-19) Situation Report – 51. 2020. Available from https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10. (Accessed March 2020). [Google Scholar]
  2. Deutsche Bundesregierung (2020), Sozialkontakte vermeiden, Ausbreitung verlangsamen. 2020. Available from URL: https://www.bundesregierung.de/breg-de/themen/coronavirus/mpk-1730186. (Accessed March 2020). [Google Scholar]
  3. Bayerisches Ministerialblatt BayMBI (2020), Nr. 151 vom 25.03.2020 zum 19.03.20, Az G24-K9000-2020/125. [Google Scholar]
  4. van Kasteren PB, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A, Molenkamp R, Reusken CBEM, Meijer A (2020), Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol 128, 104412. https://doi.org/10.1016/j.jcv.2020.104412. [CrossRef] [PubMed] [Google Scholar]
  5. Okamaoto K, Shirato K, Nao N, Saito S, Kageyama T, Hasegawa H, Suzuki T, Matsuyama S, Takeda M (2020), An assessment of real-time RT-PCR kits for SARS-CoV-2 detection. Jpn J Infect Dis. https://doi.org/10.7883/yoken.JJID.2020.108. [Google Scholar]
  6. Coronarvirus Karte für Deutschland. Wie sich das Coronavirus in Ihrer Region ausbreitet, Die Zeit, Apr 19, 2020. Available from: https://www.zeit.de/wissen/gesundheit/coronavirus-echtzeit-karte-deutschland-landkreise-infektionen-ausbreitung. (Access April 2020). [Google Scholar]
  7. Landratsamt Dachau. Gemeinden- und Anwohnerzahlen. 2020. Available from: https://www.landratsamt-dachau.de/landkreis-kultur-tourismus/landkreis/gemeinden-einwohnerzahlen. (Access April 2020). [Google Scholar]
  8. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Hoelscher M, Bleicker T, Brünink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C (2020), Virological assessment of hospitalized patients with COVID-2019. Nature. https://doi.org/10.1038/s41586-020-2196-x. [Google Scholar]
  9. Sachs L (1968), Statistische Anwendungsmethoden, Springer-Verlag, Berlin, Heidelberg, New York. [Google Scholar]
  10. Ehrlich H, McKenney M, Elkbuli A (2020), A Strategic planning and recommendations for healthcare workers during the COVID-19 pandemic. Am J Emerg Med S0735–6757, 20, 30213–30218. https://doi.org/10.1016/j.ajem.2020.03.057. [Google Scholar]
  11. Rocklöv J, Sjödin H, Wilder-Smith A (2020), COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med Feb 28, 2020, pii: taaa030. https://doi.org/10.1093/jtm/taaa030. [Google Scholar]
  12. Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, Huang J, He N, Yu H, Lin X, Wei S, Wu T (2020), Association of public Health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA 323, 19, 1–9. https://doi.org/10.001/jama.2020.6130. [Google Scholar]
  13. Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS (2017), The basic reproduction number (R₀) of measles: a systematic review. Lancet Infect Dis 17, 12, e420–2428. https://doi.org/10.1016/S1473-3099(17)30307-9. [CrossRef] [PubMed] [Google Scholar]
  14. Wang Y, Wang Y, Chen Y, Qin Q (2020), Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol Mar 05, 2020. https://doi.org/10.1002/jmv.25748. [Google Scholar]
  15. Wilder-Smith A, Chiew CJ, Lee VJ (2020), Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis 20, 5, e102–e107. https://doi.org/10.1016/S1473-3099(20)30129-8. [CrossRef] [PubMed] [Google Scholar]
  16. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020), Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China. JAMA 323, 11, 1061–1069. https://doi.org/10.1001/jama.2020.1585. [PubMed] [Google Scholar]
  17. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish Z, Oh M-D, Sall AA, Schuchat A, Ungchusak K, Wieler LH (2020), COVID-19: towards controlling of a pandemic. Lancet 395, 10229, 1015–1018. https://doi.org/10.1016/S0140-6736(20)30673-5. [CrossRef] [PubMed] [Google Scholar]
  18. Lake MA (2020), What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond) 20, 2, 124–127. https://doi.org/10.7861/clinmed.2019-coron. [CrossRef] [PubMed] [Google Scholar]
  19. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M (2020), Presumed asymptomatic carrier transmission of COVID-19. JAMA 323, 14, 1406–1407. https://doi.org/10.1001/jama.2020.2565. [PubMed] [Google Scholar]
  20. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Zu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen H-L, Peiris M, Wu J (2020), SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 382, 12, 1177–1179. https://doi.org/10.1056/NEJMc2001737. [Google Scholar]
  21. Doremalen NV, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ (2020), Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382, 16, 1564–1567. https://doi.org/10.1056/NEJMc2004973. [Google Scholar]
  22. Volkin S (2020), How long can the virus that causes COVID-19 live on surfaces? John-Hopkins Interview with Carolyn Machamer. Available at: https://hub.jhu.edu/2020/03/20/sars-cov-2-survive-on-surfaces/. [Access May 2020]. [Google Scholar]
  23. Guo Z-D, Wang Z-Y, Zhang S-F, Li X, Li L, Li C, Dong Y-Z, Chi X-Y, Zhang K, Gao Y-W, Lu B, Chen W (2020), Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China. Emerg Infect Dis 26, 7, Online ahead of print. https://doi.org/10.3201/eid2607.200885. [Google Scholar]
  24. Colaneri M, Seminari E, Novati S, Asperges E, Biscarini S, Piralla A, Percivalle E, Cassaniti I, Baldanti F, Bruno R, Mondelli MU (2020), SARS-CoV-2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit. Clin Microbiol Infect May 22, 2020, S1198-743X(20)30286-X. https://doi.org/10.1016/j.cmi.2020.05.009. [Google Scholar]
  25. Jiang FC, Jiang XL, Wang ZG, Meng ZH, Shao SF, Anderson BD, Ma MJ (2020), Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms. Emerg Infect Dis 269. https://doi.org/10.3201/eid2609.201435. [Google Scholar]
  26. Chow EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, Huntington-Frazier M, Reddy SC, Rao AK (2020), Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington. JAMA e206637. https://doi.org/10.1001/jama.2020.6637. [Google Scholar]
  27. Burrer SL, de Perio MA, Hughes MM, Kuhar DT, Luckhaupt SE, McDaniel CJ, Porter RM, Silk B, Stuckey MJ, Walters M, for the CDC COVID-19 response team (2020), Characteristics of Health Care Personnel with COVID-19 — United States. MMWR Morb Mortal Wkly Rep 69, 15, 477–481. https://doi.org/10.15585/mmwr.mm6915e6. [CrossRef] [PubMed] [Google Scholar]
  28. Brücher BLDM, Nigri G, Tinelli A, Lapeña JFF Jr., Espin-Basany E, Macri P, Matevossian E, Ralon S, Perkins R, Lück R, Kube R, da Costa JSC, Mintz Y, Tez M, Allert S, Sökmen S, Spychala A, Zilberstein B, Marusch F, Kermansaravi M, Kycler W, Vicente D, Scherer MA, Rivkind A, Elias N, Wallner G, Roviello F, Santos LL, Araujo RJC Jr., Szold A, Oleas R, Rupnik MS, Salber J, Jamall IS, Engel A (2020), COVID-19: Pandemic surgery guidance. 4open 3, 1, 1–19. https://doi.org/10.1051/fopen/2020002. [CrossRef] [EDP Sciences] [Google Scholar]
  29. Keeley AJ, Evans C, Colton H, Ankcorn M, Cope A, State A, Bennett T, Giri P, de Silva TI, Raza M (2020), Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom. Euro Surveill 25, 14, 2000433. https://doi.org/10.2807/1560-7917.ES.2020.25.14.2000433. [Google Scholar]
  30. Chua F, Armstrong-James D, Desai SR, Barnett J, Kouranos V, Kon OM, José R, Vancheeswaran R, Loebinger MR, Wong J, Cutino-Moguel MT, Morgan C, St Ledot, Lams B, Yip WH, Li L, Lee YC, Draper A, Kho SS, Renzoni E, Ward K, Periselneris J, Grubnic S, Lipman M, Wells AU, Devaraj A (2020), The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions. Lancet Respir Med S2213–2600, 20, 30132–30136. https://doi.org/10.1016/S2213-2600(20)30132-6. [Google Scholar]
  31. Bauchner H, Sharfstein J (2020), A bold response to the COVID-19 pandemic medical students, National Service, and Public Health. JAMA https://doi.org/10.1001/jama.2020.6166.. [Google Scholar]
  32. Popovich N, Sanger-Katz M (2020), The Upshot: The World Is Still Far From Herd Immunity for Coronavirus, The New York Times, May 28, 2020. Available at: https://www.nytimes.com/interactive/2020/05/28/upshot/coronavirus-herd-immunity.html. [Access May 2020]. [Google Scholar]
  33. Editorial (2020), COVID-19: Protecting Health-Care Workers. Lancet 395, 10228, 922. https://doi.org/10.1016/S0140-6736(20)30644-9. [Google Scholar]
  34. Lippi G, Simundic AM, Plebani M (2020), Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19), Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-0285. [Google Scholar]
  35. Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J (2020), Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by Time Since Exposure. Ann Intern Med M20–1495. https://doi.org/10.7326/M20-1495. [Google Scholar]
  36. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang Q, Xu S, Zhu H, Xu Y, Jin Q, Sharma L, Wang L, Wang J (2020), Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis ciaa310. 2020, https://doi.org/10.1093/cid/ciaa310. [Google Scholar]
  37. Danis K, Epaulard O, Bénet T, Investigation Team, et al. (2020), Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020. Clin Infect Dis. [PMID: 32277759] https://doi.org/10.1093/cid/ciaa424 Google Scholar [Google Scholar]
  38. Kim ES, Chin BS, Kang CK, et al. (2020), Korea National Committee for Clinical Management of COVID-19. Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean cohort study on COVID-19. J Korean Med Sci 35, e142. https://doi.org/10.3346/jkms.2020.35.e142 Google Scholar. [CrossRef] [PubMed] [Google Scholar]
  39. Zhao J, Yuan Q, Wang H, et al. (2019), Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa344 Google Scholar. [Google Scholar]
  40. Liu L, Liu W, Zheng Y, Jiang X, Kou G, Ding J, Wang Q, Huang Q, Ding Y, Ni W, Wu W, Tang S, Tan L, Hu Z, Xu W, Zhang Y, Zhang B, Tang Z, Zhang X, Li H, Rao Z, Jiang H, Ren X, Wang S, Zheng S (2020), A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients. Microbes Infect, S1286–4579(20)30086-1. https://doi.org/10.1016/j.micinf.2020.05.008. [Google Scholar]
  41. Kujawski SA, Wong KK, Collins JP, Epstein L, Killerby ME, Midgley CM, Abedi GR, Ahmed NS, Almendares O, Alvarez FN, Anderson KN, Balter S, Barry V, Bartlett K, Beer K, Ben-Aderet MA, Benowitz I, Biggs H, Binder AM, Black SR, Bonin B, Brown CM, Bruce H, Bryant-Genevier J, Budd A, Buell D, Bystritsky R, Cates J, Charles EM, Chatham-Stephens K, Chea N, Chiou H, Christiansen D, Chu V, Cody S, Cohen M, Conners E, Curns A, Dasari V, Dawson P, DeSalvo T, Diaz G, Donahue M, Donovan S, Duca LM, Erickson K, Esona MD, Evans S, Falk J, Feldstein LR, Fenstersheib M, Fischer M, Fisher R, Foo C, Fricchione MJ, Friedman O, Fry AM, Galang RR, Garcia MM, Gerber SI, Gerrard G, Ghinai I, Gounder P, Grein J, Grigg C, Gunzenhauser JD, Gutkin GI, Haddix M, Hall AJ, Han G, Harcourt J, Harriman K, Haupt T, Haynes A, Holshue M, Hoover C, Hunter JC, Jacobs MW, Jarashow C, Jhung MA, Joshi K, Kamali T, Kamili S, Kim L, Kim M, King J, Kirking HL, Kita-Yarbro A, Klos R, Kobayashi M, Kocharian A, Komatsu KK, Koppaka R, Layden KE, Li Y, Lindquist S, Lindstrom S, Link-Gelles R, Lively J, Livingston M, Lo K, Lo J, Lu X, Lynch B, Madoff L, Malapati L, Marks G, Marlow M, Mathisen GE, McClung N, McGovern O, McPherson TD, Mehta M, Meier A, Mello L, Moon SS, Morgan M, Moro RN, Murray J, Murthy R, Novosad S, Oliver SE, O’Shea J, Pacilli M, Paden CR, Pallansch MR, Patel M, Patel S, Pedraza I, Pillai SK, Pindyck T, Pray I, Queen K, Quick N, Reese H, Rha B, Rhodes H, Robinson S, Robinson P, Rolfes M, Routh J, Rubin R, Rudman SL, Sakthivel SK, Scott S, Shepherd C, Shetty V, Smith EA, Smith S, Stierman B, Stoecker W, Sunenshine R, Sy-Santos R, Tamin A, Tao Y, Terashita D, Thornburg NJ, Tong S, Traub E, Tural A, Uehara A, Uyeki TM, Vahey G, Verani JR, Villarino E, Wallace M, Wang L, Watson JT, Westercamp M, Whitaker B, Wilkerson S, Woodruff RC, Wortham JM, Wu T, Xie A, Yousaf A, Zahn M, Zhang J (2020), Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States, Apr 23, 2020. Nature Med. https://doi.org/10.1038/s41591-020-0877-5. [Google Scholar]
  42. Roche Molecular Systems, Inc (2020), cobas® SARS-CoV-2: Qualitative assay for use on the cobas® 6800/8800 Systems – For use under the Emergency Use Authorization (EUA) only – For in vitro diagnostic use, 09179917001–03EN, Doc Rev. 3.0. Available at https://www.fda.gov/media/136049/download. (Access May 2020). [Google Scholar]
  43. Broder K, Babiker A, Myers C, White T, Jones H, Cardella J, Burd EM, Hill CE, Kraft CS (2020), Test agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges. J Clin Microbiol JCM.01187-20. https://doi.org/10.1128/JCM.01187-20. [Google Scholar]
  44. Pujadas E, Ibeh N, Hernandez MM, Waluszko A, Sidorenko T, Flores V, Shiffrin B, Chiu N, Young-Francois A, Nowak MD, Paniz-Mondolfi AE, Sordillo EM, Cordon-Cardo C, Houldsworth J, Gitman MR (2020), Comparison of SARS-CoV-2 detection from nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a laboratory-developed real-time RT-PCR test. J Med Virol. . https://doi.org/1002/jmv.25988. [Google Scholar]
  45. Poljak M, Korva M, Knap Gašper N, Fujs Komloš K, Sagadin M, Uršič T, Avšič Županc T, Petrovec M (2020), Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic. J Clin Microbiol 58, 6, e00599–20. https://doi.org/10.1128/JCM.00599-20. [PubMed] [Google Scholar]
  46. Lieberman JA, Pepper G, Naccache SN, Huang ML, Jerome KR, Greninger AL (2020), Comparison of commercially available and laboratory developed assays for in vitro detection of SARS-CoV-2 in clinical laboratories. J Clin Microbiol JCM.00821-20. https://doi.org/10.1128/JCM.00821-20. [Google Scholar]
  47. Fontanarosa PB, Bauchner H (2020), COVID-19 – Looking beyond tomorrow for health care and society. JAMA https://doi.org/10.1001/jama.2020.658. [Google Scholar]
  48. Food and Drug Administration (FDA) (2020), Emergency Situation (Medical Devices): EUA Authorized Serology Test Performance, May 22, 2020. Available at https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performance. [Access May 2020]. [Google Scholar]
  49. Von Freyburg A, Hagedorn H, Brücher BLDM, Schmidt A, Scherer MA (2020), COVID-19-Cluster Studie an einem Lehrkrankenhaus. MMW – Fortschr Med 162, 9, 64–67. https://doi.org/10.1007/s15006-020-0482-z. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.